~~<i id='76E158B845'><strike id='76E158B845'><tt id='76E158B845'><pre id='76E158B845'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：focus 2025-08-12 09:09:12 - browse：697

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Clinicians often fail to acknowledge the pain caused by long Covid

focus

Wikipedia

leisure time

entertainment

hotspot

leisure time

AdobeLONDON—TheWellcomeTrust—theworld’ssecondlargestprivatefunderofbiomedicalresearch—announcedonWed

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Decentralized clinical trials need collaboration to achieve wider use

Medical students need to learn the potent medicine of empathy

Stroke rates rising, especially in working

Humana CEO Bruce Broussard to step down in 2024

Why we need mandatory labeling of GMO products

hotspot

focus

focus

Novavax promises a turnaround & Lilly roils the obesity market

STAT Readout: Today's biotech news includes Sana and Amylyx

Tori Bowie and the unacceptable rates of Black maternal death

European regulators recommend Amylyx's ALS drug be rejected

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Readout Newsletter: Today in biotech, life science news

In age of alternative facts, a scholarly course on calling out crap

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Medical leaders decry Supreme Court decision on affirmative action

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Wikipedia

Massive project maps cells in human brain in unprecedented detail

Medical students need to learn the potent medicine of empathy

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Life sciences deals on track to hit lowest point since 2017

Massive project maps cells in human brain in unprecedented detail

leisure time

entertainment

hotspot

leisure time